… coronavirus disease 2019 (COVID-19) and the enhancement … on the mechanism of COVID-19
induced intestinal microbiota … 存有潜在持续影响,本文对COVID-19所致肠道微生物 群及相关…

… COVID-19已发生多次变异,虽然COVID-19感染的患者症状越来越轻,但探究其致病机制及与呼吸
系统的关系仍具有重要意义.COVID-19… 本文就COVID-19引起消化道症状的机制及益生菌作为…

… Ⅱ期临床试验,评估IMU-838 治 疗COVID-19,溃疡性结肠炎(ulcerative colitis, UC),原发性硬化性
胆管… The selective oral immunomodulator vidofludimus in patients with active rheu⁃ matoid …

… 探讨血必净注射液治疗新型冠状病毒肺炎(COVID-19)的潜在调 控机制.方法借助中药系统药理
… 中COVID-19基因相关靶标使 用R编程语言取交集,从而获得血必净注射液治疗COVID-19的核心…

… 在MSCs治疗COVID⁃19的研究中 发现,MSCs的输注促进了SARS⁃CoV⁃2特异性抗体 的维持
,… of mesenchymal stem cells in murine colitis through immunomodulation and epi⁃ thelial …

… inflammatory bowel disease, IBD)是一种慢性非特异性的肠道炎症性疾病,目前 病因不明,发病
机制尚不十分清楚.IBD好发于青壮 年人群,有溃疡性结肠炎(ulcerative colitis… by COVID-19 on the …

… , differentiation, apoptosis, and immunomodulation. Since the first JAK … IBD 患者肠道中的
黏膜细胞会释放促炎 … 结果显示,该治疗方案能够降低 COVID-19 患者的死亡率且导致严重不良…

… , and guided by the theory of traditional Chinese medicine, the modern technology of MSCs
has achieved good results in the application of refractory diseases such as COVID⁃19, and …

… stem cell treatment of COVID-19 have been conducted, and … stem cell therapy for COVID-19,
we should also catch sight of … The immunomodulatory function of mesenchymal stem cells: …

… infection related neurological disease symptoms, may be of considerable importance for
further investigation, including in relation to longer term neurological outcomes in COVID-19 …